A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates
Cairo MS, Agosti J, Ellis R, Laver JJ, Puppala B, DeLemos R, Givner L, Nesin M, Wheeler JG, Seth T, Van d, Fanaroff A. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr. 1999; 134(1):64 - 70.